Skip to main content
fr
en
Toggle navigation
Main navigation
Company
Company profile
Management
Our history
Great Place to Work
Science
Scientific approach
Innate Immunity & NK cells
Antibody formats
ANKET: Our NK cell engager Platform
Publications
Products
Pipeline overview
Clinical trials
------------------
Lacutamab
Monalizumab
Avdoralimab
IPH5201
IPH5301
IPH6101
IPH62
------------------
LUMOXITI
Partnering
Investors
Overview
News & Events
Financial and Regulatory Information
General Shareholders Meeting
Share Information
Investor Kit
Corporate Governance
Media
Media hub
All press releases
Media center
Careers
Home
Media center
IUIS-Frontiers Webinar Series on COVID-19: Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis - Eric Vivier
Tue, 06/23/2020 - 10:45
Category
Science
